Table 2.
Demographic and clinical characteristics of patients with primary intraocular lymphoma
| Variables | Total | <60 | ≥ 60 | P |
|---|---|---|---|---|
| Number of patients(%) | 326 | 91 | 235 | |
| Age | ||||
| Mean (SD) | 66.1(14.2) | 48.5(10.4) | 72.9(8.6) | |
| Median [Min, Max] | 67.5[8,97] | 52[8,59] | 72[60–97] | |
| Year of diagnosis | 0.059 | |||
| 1992–2002 | 76(23.3) | 18(19.8) | 58(24.7) | |
| 2003–2012 | 138(42.3) | 48(52.7) | 90(38.3) | |
| 2013–2018 | 112(34.4) | 25(27.5) | 87(37) | |
| Sex | 0.208 | |||
| Male | 129(39.6) | 41(45.1) | 88(37.4) | |
| Female | 197(60.4) | 50(54.9) | 147(62.6) | |
| Race | 0.105 | |||
| White | 275(84.4) | 72(79.1) | 203(86.4) | |
| Othersa | 51(15.6) | 19(20.9) | 32(13.6) | |
| Laterality | 0.202 | |||
| Unilateral | 274(84) | 78(85.7) | 196(83.4) | |
| Bilateral | 44(13.5) | 13(14.3) | 31(13.2) | |
| Unknown | 8(2.5) | 8(3.4) | ||
| Primary site | 0.185 | |||
| Retina | 12(3.7) | 12(5.1) | ||
| Choroid | 24(7.4) | 7(7.7) | 17(7.2) | |
| Ciliary body | 66(20.2) | 19(20.9) | 47(20) | |
| Vitreous | 224(68.7) | 65(71.4) | 159(67.7) | |
| Pathological type | 0.003 | |||
| DLBCL | 99(30.4) | 18(19.8) | 81(34.5) | |
| MALT | 88(27) | 37(40.7) | 51(21.7) | |
| NHL, NOS | 56(17.2) | 13(14.3) | 43(18.3) | |
| Other/unclassifiedb | 83(25.5) | 23(25.3) | 60(25.5) | |
| Ann arbor stage | 0.839 | |||
| I to II | 209(64.1) | 58(63.7) | 151(64.3) | |
| III to IV | 31(9.5) | 10(11) | 21(8.9) | |
| Unknown | 86(26.4) | 23(25.3) | 63(26.8) | |
| Surgery | 0.153 | |||
| No | 232(71.2) | 70(76.9) | 162(68.9) | |
| Performed | 94(28.8) | 21(23.1) | 73(31.1) | |
| Radiotherapy | 0.757 | |||
| No/unknown | 180(55.2) | 49(53.8) | 131(55.7) | |
| Performed | 146(44.8) | 42(46.2) | 104(44.3) | |
| Chemotherapy | 0.978 | |||
| No/unknown | 201(61.7) | 56(61.5) | 145(61.7) | |
| Performed | 125(38.3) | 35(38.5) | 90(38.3) | |
Othersa: Black,American Indian/AK Native,Asian/Pacific Islander,and unknown
Other/unclassifiedb: Malignant lymphoma,Mantle cell lymphoma, Burkitt lymphoma,Follicular lymphoma, Peripheral T-cell lymphoma, Anaplastic large cell lymphoma, Chronic lymphocytic leukemia/small lymphocytic lymphoma
NHL Non–Hodgkin lymphoma, NOS Not otherwise specified